Amélie Forest

1000 total citations
10 papers, 302 citations indexed

About

Amélie Forest is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amélie Forest has authored 10 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amélie Forest's work include Growth Hormone and Insulin-like Growth Factors (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Amélie Forest is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Amélie Forest collaborates with scholars based in United States, Spain and Italy. Amélie Forest's co-authors include M. Neal Waxham, Matthew T. Swulius, Ruslan D. Novosiadly, Yoshihisa Kubota, Joyce Ka Yu Tse, J. Michael Bradshaw, Tara Gaertner, Shande Tang, Jan Cosaert and Tuan S. Nguyen and has published in prestigious journals such as Biochemistry, Cancer Research and The Journal of Comparative Neurology.

In The Last Decade

Amélie Forest

10 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amélie Forest United States 8 161 106 64 50 44 10 302
Yingxiao Chen China 14 300 1.9× 129 1.2× 89 1.4× 17 0.3× 58 1.3× 24 630
K. Tate United States 9 281 1.7× 54 0.5× 62 1.0× 43 0.9× 33 0.8× 12 537
Dirk H. Siepe United States 8 422 2.6× 109 1.0× 30 0.5× 91 1.8× 24 0.5× 11 569
David Ketelsen United States 8 285 1.8× 113 1.1× 76 1.2× 74 1.5× 43 1.0× 10 434
Haiyan Huang China 9 108 0.7× 66 0.6× 47 0.7× 16 0.3× 48 1.1× 22 259
George A. Abou-Rjaily United States 6 241 1.5× 90 0.8× 24 0.4× 16 0.3× 22 0.5× 6 394
Hiroyuki Soga Japan 13 175 1.1× 41 0.4× 21 0.3× 14 0.3× 18 0.4× 33 413
Xinyue Lv China 10 160 1.0× 62 0.6× 75 1.2× 12 0.2× 33 0.8× 27 366
Jeegar Patel United States 9 147 0.9× 117 1.1× 41 0.6× 53 1.1× 29 0.7× 25 426
Dawn Kohrt United States 9 209 1.3× 72 0.7× 137 2.1× 35 0.7× 9 0.2× 9 351

Countries citing papers authored by Amélie Forest

Since Specialization
Citations

This map shows the geographic impact of Amélie Forest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Forest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Forest more than expected).

Fields of papers citing papers by Amélie Forest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélie Forest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Forest. The network helps show where Amélie Forest may publish in the future.

Co-authorship network of co-authors of Amélie Forest

This figure shows the co-authorship network connecting the top 25 collaborators of Amélie Forest. A scholar is included among the top collaborators of Amélie Forest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélie Forest. Amélie Forest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Forest, Amélie, David Schaer, Ting Chen, et al.. (2018). Abstract 3632: Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models. Cancer Research. 78(13_Supplement). 3632–3632. 1 indexed citations
2.
Donoho, Gregory P., Philip W. Iversen, Youyan Zhang, et al.. (2017). Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations. Clinical Cancer Research. 23(18). 5547–5560. 39 indexed citations
3.
Bagchi, Atrish, Jaafar N. Haidar, Scott W. Eastman, et al.. (2017). Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance. Molecular Cancer Therapeutics. 17(2). 521–531. 46 indexed citations
4.
Dempsey, Jack, Lysiane Huber, Amélie Forest, et al.. (2017). Abstract 583: The CDK4/6 inhibitor abemaciclib induces synergistic immune activation and antitumor efficacy in combination with PD-L1 blockade. Cancer Research. 77(13_Supplement). 583–583. 2 indexed citations
5.
Novello, Silvia, Giorgio V. Scagliotti, Gilberto de Castro, et al.. (2016). An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(2). 383–389. 20 indexed citations
6.
Gradishar, William J., Denise A. Yardley, Rachel M. Layman, et al.. (2015). Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy. Clinical Cancer Research. 22(2). 301–309. 54 indexed citations
7.
Forest, Amélie, Dale L. Ludwig, Ying Wang, et al.. (2015). Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor. Molecular Cancer Research. 13(12). 1615–1626. 27 indexed citations
8.
Valle, Jorge Reyes‐del, Cynthia de la Fuente, Christoph Springfeld, et al.. (2012). Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster. Journal of Virology. 86(21). 11558–11566. 35 indexed citations
9.
Swulius, Matthew T., Yoshihisa Kubota, Amélie Forest, & M. Neal Waxham. (2010). Structure and composition of the postsynaptic density during development. The Journal of Comparative Neurology. 518(20). 4243–4260. 38 indexed citations
10.
Forest, Amélie, Matthew T. Swulius, Joyce Ka Yu Tse, et al.. (2008). Role of the N- and C-Lobes of Calmodulin in the Activation of Ca2+/Calmodulin-Dependent Protein Kinase II. Biochemistry. 47(40). 10587–10599. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026